New AI-powered anomaly detection and in-memory processing capabilities in the Oracle Utilities Customer Platform are helping deliver fast, accurate meter data management (MDM) and streamlining utility ...

This TDWI Best Practices Report identifies current challenges organizations are facing with data strategy and management, as well as shared modernization priorities for achieving data-driven business ...

ISMG's Data Security Dallas Summit in Dallas delivered a dynamic forum for leaders confronting data risk. The sessions ...

Hello again! Welcome back to Scaling Greatness, a newsletter from Integreon focusing on amplifying business excellence and ...

The data presented is from a Phase 1/2 clinical study (NCT05636215) aimed at evaluating the safety, tolerability, and preliminary efficacy of IBI354 in participants with advanced solid tumors.

Your client is not just looking for numbers. They are looking for meaning behind those numbers. By understanding their vision, fears, and personal motivations, you become part of their core team — ...

The model proposed in this paper hypothesises that the pathology and the response to treatment are different in these presentations ... of the pathology is still possible with load management and ...

2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from the Phase 1 PoC Clinical Study in Advanced Non ...

The updated findings showed promising efficacy data from 21 heavily pre-treated pancreatic ductal ... University of Colorado Anschutz School of Medicine. This presentation follows the recent Fast ...

IBI363 shows remarkable efficacy in immune-resistant wild-type nsclc and clinical data suggests better trends in ORR, DCR, PFS and OS at higher doses. We expect longer-term follow-up to bring more ...

The data presented is from a Phase 1/2 clinical study (NCT05636215) aimed at evaluating the safety, tolerability, and preliminary efficacy of IBI354 in participants with advanced solid tumors. As of ...

SINGAPORE I June 3, 2025 I The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development, has announced the presentation of updated clinical data ...